Literature DB >> 2401562

Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis.

L P Kahl1, R Lelchuk, C A Scott, J Beesley.   

Abstract

Leishmania major antigen-liposomes prepared as dehydration-rehydration vesicles (DRV) and composed of equimolar amounts of L-alpha-distearoyl phosphatidylcholine and cholesterol confer high-level host-protective immunity against virulent homologous challenge to susceptible BALB/c mice. Physical and antigenic characterization of these protective liposomes is described. Both empty and L. major antigen-DRV were multilamellate and heterogeneous in size, ranging from 0.10 to 2.00 microns. Although the liposomes were made by using a crude mixture of promastigote antigens, lipophosphoglycan covered the liposome surface; this was demonstrated by immunogold electron microscopy. Application of sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blot (immunoblot) analysis revealed preferential entrapment of the 63-kilodalton promastigote protease (gp63) into the DRV. We suggest that our L. major antigen-DRV merit further study because of their preferential entrapment of these two host protective antigens together with their long in vivo half-life. In addition, this report illustrates that intravenous or subcutaneous immunization of BALB/c mice with the same limited subset of protective antigens, predominantly lipophosphoglycan and gp63, within DRV liposomes leads to either protection and low splenic interleukin-3 production or to nonprotection and high splenic interleukin-3 production, respectively. This was consistent with our hypothesis that differential antigen presentation after administration of the same immunogen by the intravenous or the subcutaneous route results in differential T-cell activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2401562      PMCID: PMC313644          DOI: 10.1128/iai.58.10.3233-3241.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  The promastigote surface protease of Leishmania.

Authors:  C Bordier
Journal:  Parasitol Today       Date:  1987-05

2.  Monoclonal antibody affinity purification of a Leishmania membrane glycoprotein and its inhibition of leishmania-macrophage binding.

Authors:  C S Chang; K P Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

3.  Morphological observations on the cellular and subcellular destination of intravenously administered liposomes.

Authors:  A W Segal; E J Wills; J E Richmond; G Slavin; C D Black; G Gregoriadis
Journal:  Br J Exp Pathol       Date:  1974-08

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Structural and antigenic characterization of a species- and promastigote-specific Leishmania mexicana amazonensis membrane protein.

Authors:  L P Kahl; D McMahon-Pratt
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

Review 6.  The way ahead for vaccines and vaccination: symposium summary.

Authors:  G F Mitchell
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

7.  Antibodies raised against synthetic peptides from the Arg-Gly-Asp-containing region of the Leishmania surface protein gp63 cross-react with human C3 and interfere with gp63-mediated binding to macrophages.

Authors:  D G Russell; P Talamas-Rohana; J Zelechowski
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

8.  Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components.

Authors:  J Senior; G Gregoriadis
Journal:  Life Sci       Date:  1982-06-14       Impact factor: 5.037

9.  Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection.

Authors:  G F Mitchell; E Handman; T W Spithill
Journal:  Aust J Exp Biol Med Sci       Date:  1984-04

10.  Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of antiimmunoglobulin presented by small B lymphocytes.

Authors:  H P Tony; D C Parker
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

View more
  9 in total

1.  Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice.

Authors:  Farhat Afrin; Ravindran Rajesh; Khairul Anam; Meenakshisundram Gopinath; Swati Pal; Nahid Ali
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

2.  Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid.

Authors:  C A Bate; J Taverne; E Román; C Moreno; J H Playfair
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

3.  Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.

Authors:  C A Guzman; G Molinari; M W Fountain; M Rohde; K N Timmis; M J Walker
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

4.  Efficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier.

Authors:  Shinobu Watarai; Tana Iwase; Tomoko Tajima; Eiji Yuba; Kenji Kono
Journal:  ScientificWorldJournal       Date:  2013-02-04

5.  Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection.

Authors:  Saumyabrata Mazumder; Mithun Maji; Nahid Ali
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20

6.  Vaccine Development Against Leishmania donovani.

Authors:  Amrita Das; Nahid Ali
Journal:  Front Immunol       Date:  2012-05-15       Impact factor: 7.561

7.  Induction of antibody response in the oral cavity of dogs following intraocular (eye drop) immunization with Porphyromonas gingivalis cell lysate incorporated in pH-sensitive fusogenic polymer-modified liposomes.

Authors:  Yosuke Shimizu; Tadashi Iwasaki; Tomoko Tajima; Eiji Yuba; Kenji Kono; Shinobu Watarai
Journal:  J Vet Med Sci       Date:  2016-12-05       Impact factor: 1.267

8.  Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine.

Authors:  Seiji Okazaki; Tadashi Iwasaki; Eiji Yuba; Shinobu Watarai
Journal:  J Vet Med Sci       Date:  2017-12-28       Impact factor: 1.267

9.  Alginate nanoparticles as a promising adjuvant and vaccine delivery system.

Authors:  F Sarei; N Mohammadpour Dounighi; H Zolfagharian; P Khaki; S Moradi Bidhendi
Journal:  Indian J Pharm Sci       Date:  2013-07       Impact factor: 0.975

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.